| SpectraBase Spectrum ID |
DjhUk3G5MZs |
| Name |
1-(2-Fluorobenzyl)-4-(2-hydroxyethyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
238.148141402 u |
| Formula |
C13H19FN2O |
| InChI |
InChI=1S/C13H19FN2O/c14-13-4-2-1-3-12(13)11-16-7-5-15(6-8-16)9-10-17/h1-4,17H,5-11H2 |
| InChIKey |
ARELLQRYXAQYGS-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
238.306 g/mol |
| Nominal Mass |
238 u |
| Quality |
971 |
| Retention Index |
1789 |
| SMILES |
OCCN1CCN(CC=2C(=CC=CC2)F)CC1 |
| SPLASH |
splash10-0a4i-9860000000-8e14cb7c6e2781dabffa |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(2-fluorobenzyl)-4-(2-hydroxyethyl)
2-(4-(2-fluorobenzyl)piperazin-1-yl)ethan-1-ol |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011257 |
